chr1-1373822-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_ModerateBP6_Moderate
The ENST00000338338.10(AURKAIP1):c.579G>T(p.Lys193Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
ENST00000338338.10 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AURKAIP1 | NM_017900.3 | c.579G>T | p.Lys193Asn | missense_variant | 4/4 | ENST00000338338.10 | NP_060370.1 | |
AURKAIP1 | NM_001127229.2 | c.579G>T | p.Lys193Asn | missense_variant | 4/4 | NP_001120701.1 | ||
AURKAIP1 | NM_001127230.2 | c.579G>T | p.Lys193Asn | missense_variant | 4/4 | NP_001120702.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AURKAIP1 | ENST00000338338.10 | c.579G>T | p.Lys193Asn | missense_variant | 4/4 | 1 | NM_017900.3 | ENSP00000340656 | P1 | |
AURKAIP1 | ENST00000338370.7 | c.579G>T | p.Lys193Asn | missense_variant | 3/3 | 1 | ENSP00000342676 | P1 | ||
AURKAIP1 | ENST00000321751.9 | c.579G>T | p.Lys193Asn | missense_variant | 4/4 | 2 | ENSP00000319778 | P1 | ||
AURKAIP1 | ENST00000378853.3 | c.579G>T | p.Lys193Asn | missense_variant | 4/4 | 2 | ENSP00000368130 | P1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1449574Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 721510
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 11, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.